Últimas publicaciones
Observed versus predicted mortality after MitraClip treatment in patients with symptomatic heart failure and significant functional mitral regurgitation.
Eur J Heart Fail. 2018 Oct;20(10):1495-1496. doi: 10.1002/ejhf.1291. Epub 2018 Aug 23.
Godino C, Scotti A, Munafò A, Taramasso M, Adamo M, Russo M, Toscano E, Salerno A, Cappelletti A, Stella S, Fragasso G, Montorfano M, Agricola E, Ettori F, Margonato A, Maisano F, Colombo A.
Safety and efficacy of Direct Oral Anticoagulants (DOACs) in very elderly patients (≥ 85 years old) with non-valvular atrial fibrillation. The Experience of an Italian tertiary care center.
Minerva Med. 2021 Jun 28. doi: 10.23736/S0026-4806.21.07432-2. Online ahead of print. PMID: 34180639
Rubino C, Blunda F, Bodega F, Melillo F, Russi A, Mattiello P, Salerno A, Cera M, Margonato D, Mazzone P, Della Bella P, Castiglioni A, Alfieri O, DE Bonis M, Montorfano M, Filippi M, Tresoldi M, Cappelletti A, Zangrillo A, Margonato A, Godino C; INSigHT (Italian DOACs San Raffaele Hospital) registry investigators.
Direct oral anticoagulants in patients with nonvalvular atrial fibrillation and extreme body weight.
Eur J Clin Invest. 2022 Jan;52(1):e13658. doi: 10.1111/eci.13658. Epub 2021 Aug 10. PMID: 34310688
Bodega F, Russi A, Melillo F, Blunda F, Rubino C, Leo G, Cappelletti A, Mazzone P, Mattiello P, Della Bella P, Castiglioni A, Alfieri O, De Bonis M, Montorfano M, Tresoldi M, Filippi M, Salerno A, Cera M, Zangrillo A, Alberto M, Godino C; INSigHT (Italian DOACs San Raffaele Hospital) registry investigators.
Long-term clinical effects of recanalization of chronic coronary total occlusions in patients with left ventricular systolic dysfunction.
Catheter Cardiovasc Interv. 2020 Oct 1;96(4):831-838. doi: 10.1002/ccd.28850. Epub 2020 Mar 18. PMID: 32187806
Pinto G, Fragasso G, Gemma M, Bertoldi L, Salerno A, Godino Md C, Colombo A, Azzalini L, Margonato A, Carlino M.
Effectiveness and cost-efficacy of diuretics home administration via peripherally inserted central venous catheter in patients with end-stage heart failure.
Int J Cardiol. 2022 Oct 15;365:69-77. doi: 10.1016/j.ijcard.2022.07.025. Epub 2022 Jul 16. PMID: 35853499
Godino C, Scotti A, Marengo A, Battini I, Brambilla P, Stucchi S, Slavich M, Salerno A, Fragasso G, Margonato A.
Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy.
Int J Cardiol. 2018 Oct 15;269:33-39. doi: 10.1016/j.ijcard.2018.06.041. Epub 2018 Jun 12. PMID: 29929931
Godino C, Scotti A, Taramasso M, Adamo M, Russo M, Chiarito M, Melillo F, Beneduce A, Pivato CA, Arrigoni L, Toscano E, Salerno A, Cappelletti A, Magni V, Stella S, Fragasso G, Montorfano M, Agricola E, Ettori F, Margonato A, Maisano F, Colombo A.
Real-world 2-year outcome of atrial fibrillation treatment with dabigatran, apixaban, and rivaroxaban in patients with and without chronic kidney disease.
Intern Emerg Med. 2019 Nov;14(8):1259-1270. doi: 10.1007/s11739-019-02100-9. Epub 2019 May 9. PMID: 31073827
Godino C, Melillo F, Rubino F, Arrigoni L, Cappelletti A, Mazzone P, Mattiello P, Della Bella P, Colombo A, Salerno A, Cera M, Margonato A; INSIghT investigators.
Inappropriate dose of nonvitamin-K antagonist oral anticoagulants: prevalence and impact on clinical outcome in patients with nonvalvular atrial fibrillation.
J Cardiovasc Med (Hagerstown). 2020 Oct;21(10):751-758. doi: 10.2459/JCM.0000000000001043. PMID: 32740435
Godino C, Bodega F, Melillo F, Rubino F, Parlati ALM, Cappelletti A, Mazzone P, Mattiello P, Della Bella P, Castiglioni A, Alfieri O, De Bonis M, Montorfano M, Tresoldi M, Filippi M, Zangrillo A, Salerno A, Cera M, Margonato A; INSIgHT (Italian NOACs San Raffaele Hospital) registry investigators.
Effects of metabolic approach in diabetic patients with coronary artery disease.
Curr Pharm Des. 2009;15(8):857-62. doi: 10.2174/138161209787582093. PMID: 19275650 Review.
Fragasso G, Salerno A, Spoladore R, Cera M, Montanaro C, Margonato A.
Resting cardiac energy metabolism is inversely associated with heart rate in healthy young adult men.
Am Heart J. 2011 Jul;162(1):136-41. doi: 10.1016/j.ahj.2011.04.012. PMID: 21742100
Fragasso G, De Cobelli F, Spoladore R, Esposito A, Salerno A, Calori G, Montanaro C, Maranta F, Lattuada G, Margonato A, Del Maschio A, Perseghin G.
Impact and evolution of right ventricular dysfunction after successful MitraClip implantation in patients with functional mitral regurgitation.
Int J Cardiol Heart Vasc. 2016 May 9;11:90-98. doi: 10.1016/j.ijcha.2016.05.017. eCollection 2016 Jun. PMID: 28616532
Godino C, Salerno A, Cera M, Agricola E, Fragasso G, Rosa I, Oppizzi M, Monello A, Scotti A, Magni V, Montorfano M, Cappelletti A, Margonato A, Colombo A.
Metabolic therapy of heart failure.
Curr Pharm Des. 2008;14(25):2582-91. doi: 10.2174/138161208786071245. PMID: 18991675 Review.
Fragasso G, Salerno A, Spoladore R, Bassanelli G, Arioli F, Margonato A.
Effects of short-term manipulation of serum FFA concentrations on left ventricular energy metabolism and function in patients with heart failure: no association with circulating bio-markers of inflammation.
Acta Diabetol. 2015 Aug;52(4):753-61. doi: 10.1007/s00592-014-0695-7. Epub 2015 Jan 7. PMID: 25559351
Salerno A, Fragasso G, Esposito A, Canu T, Lattuada G, Manzoni G, Del Maschio A, Margonato A, De Cobelli F, Perseghin G.
Beneficial electrophysiological effects of trimetazidine in patients with postischemic chronic heart failure.
J Cardiovasc Pharmacol Ther. 2010 Mar;15(1):24-30. doi: 10.1177/1074248409356431. Epub 2010 Jan 25. PMID: 20100903
Cera M, Salerno A, Fragasso G, Montanaro C, Gardini C, Marinosci G, Arioli F, Spoladore R, Facchini A, Godino C, Margonato A.
Validation of a new score for outcome prediction in patients with heart failure with reduced ejection fraction.
Minerva Cardioangiol. 2019 Jun;67(3):191-199. doi: 10.23736/S0026-4725.19.04823-0. Epub 2019 Mar 27. PMID: 30919603
Loiacono F, Fragasso G, Calori G, Alberti L, Marinosci G, Salerno A, Margonato A.
